In-patient Tolvaptan use in SIADH: care audit, therapy observation and outcome analysis

BACKGROUND: Indications for use of tolvaptan in SIADH-associated hyponatraemia remain controversial. We audited our local guidelines for Tolvaptan use in this situation to review treatment implications including drug safety, hospital admission episode analysis (episodes of liver toxicity, CNS myelin...

Descripción completa

Detalles Bibliográficos
Autores principales: Humayun, Malik Asif, Cranston, Iain C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674865/
https://www.ncbi.nlm.nih.gov/pubmed/29110656
http://dx.doi.org/10.1186/s12902-017-0214-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674865/
https://www.ncbi.nlm.nih.gov/pubmed/29110656
http://dx.doi.org/10.1186/s12902-017-0214-2

Ejemplares similares